InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
TLR4-based adjuvant - MPLA-SM VacciGrade™ | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
Quil-A® adjuvant | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
Poly(I:C) (HMW) VacciGrade™ | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
pFUSE-hIgG1-Fc | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
Poly(dA:dT) | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
PMA - Phorbol myristate acetate | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
LPS-EK (LPS from E. coli K12) | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
Plasmocure™ - Mycoplasma Elimination Reagent | Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer... | 2022 | Biomed Pharmacother. | Lin H.Y. et al. | DOI: 10.1016/j.biopha.2021.112431 |
Normocin® - Antimicrobial Reagent | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
Puromycin | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
Plasmocure™ - Mycoplasma Elimination Reagent | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
Plasmocure™ - Mycoplasma Elimination Reagent | Pantothenate and L-Carnitine Supplementation Improves Pathological Alteration... | 2022 | Genes (Basel) | Munuera-Cabeza M. et al. | DOI: 10.3390/genes13122300 |
Normocure™ - Antimicrobial Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
Fungin™ - Antifungal Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
Normocin® - Antimicrobial Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
Plasmocin® - Mycoplasma Elimination Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
Plasmocure™ - Mycoplasma Elimination Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
Normocin® - Antimicrobial Reagent | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |
Plasmocure™ - Mycoplasma Elimination Reagent | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |
Puromycin | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |